Skip to main content
logo
GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,170.00
+140.00 (2.78%)
At close: Oct 23, 2026

GeneBioTech Co. ,Ltd Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
89,31590,78982,95979,47782,75962,814
Revenue Growth
0.97%9.44%4.38%-3.96%31.75%6.25%
Gross Profit
15,28714,25613,37013,65210,3497,439
Operating Income
4,6093,9963,8443,9731,557-453.15
Net Income
3,6723,7892,8652,5911,523-484.4
Earnings Per Share
426.45440.00332.76300.95176.91-56.26
EPS Growth
2.03%32.23%10.57%70.12%--

Revenue by Segment
Chart
Fiscal Year
FY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
Unallocated Adjustments
-877.01-610.89-554.31
Korea (Gongju)
46,89046,53341,629
Korea (Ansan)
44,77637,03738,403
Total
90,78982,95979,477

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27,43624,89723,40422,01616,09017,790
Total Debt
17,44814,95715,88512,50213,02910,302
Net Cash (Debt)
9,9889,9407,5199,5143,0617,488
Net Cash Growth
110.98%32.20%-20.97%210.80%-59.12%-65.62%
Net Cash Per Share
1159.911154.38873.231104.91355.50869.68

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
5,3607,614-463.877,369-3,679-2,713
Capital Expenditures
-834.9-3,758-1,100-530.02-1,155-3,102
Free Cash Flow
4,5253,856-1,5646,838-4,834-5,816
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
17.12%15.70%16.12%17.18%12.50%11.84%
Operating Margin
5.16%4.40%4.63%5.00%1.88%-0.72%
Pretax Margin
4.82%4.86%4.22%4.25%2.19%-1.33%
Profit Margin
4.11%4.17%3.45%3.26%1.84%-0.77%
FCF Margin
5.07%4.25%-1.89%8.60%-5.84%-9.26%

Dividends
Chart
Fiscal Year
CurrentFY 2025
Period EndingOct '26 Dec '25
Dividend Per Share
50.00050.000
Dividend Per Share Growth
0%-
Dividend Yield
0.97%1.25%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.129.119.8914.4922.55-
P/FCF Ratio
9.848.95-5.49--
PS Ratio
0.500.380.340.470.420.72